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Background. Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of nosocomial infection. Here, we describe 
the utility of whole-genome sequencing in defining nosocomial VREfm transmission.
Methods. A retrospective study at a single hospital in the United Kingdom identified 342 patients with E. faecium bloodstream 
infection over 7 years. Of these, 293 patients had a stored isolate and formed the basis for the study. The first stored isolate from each 
case was sequenced (200 VREfm [197 vanA, 2 vanB, and 1 isolate containing both vanA and vanB], 93 vancomycin-susceptible E. 
faecium) and epidemiological data were collected. Genomes were also available for E. faecium associated with bloodstream infections 
in 15 patients in neighboring hospitals, and 456 patients across the United Kingdom and Ireland.
Results. The majority of infections in the 293 patients were hospital-acquired (n = 249) or healthcare-associated (n = 42). 
Phylogenetic analysis showed that 291 of 293 isolates resided in a hospital-associated clade that contained numerous discrete clusters 
of closely related isolates, indicative of multiple introductions into the hospital followed by clonal expansion associated with trans-
mission. Fine-scale analysis of 6 exemplar phylogenetic clusters containing isolates from 93 patients (32%) identified complex trans-
mission routes that spanned numerous wards and years, extending beyond the detection of conventional infection control. These 
contained both vancomycin-resistant and -susceptible isolates. We also identified closely related isolates from patients at Cambridge 
University Hospitals NHS Foundation Trust and regional and national hospitals, suggesting interhospital transmission.
Conclusions. These findings provide important insights for infection control practice and signpost areas for interventions. We 
conclude that sequencing represents a powerful tool for the enhanced surveillance and control of nosocomial E. faecium transmis-
sion and infection.
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Enterococcus faecium is a leading cause of nosocomial infec-
tions in critically ill and immunocompromised patients [1]. 
In 2009–2010, E.  faecium was among the top 10 most com-
mon microorganisms associated with healthcare-associated 
infections in the United States [1]. Vancomycin resistance in 
E. faecium (VREfm) was first reported in 1988 [2, 3] and has 
since become globally disseminated. Infections caused by van-
comycin-resistant enterococci (VRE) have limited treatment 
options, and are associated with higher mortality and health-
care costs compared with those caused by vancomycin-sus-
ceptible enterococci [4–8]. Eradication of E.  faecium from 
healthcare settings is challenging because it is often carried in 
the gut by hospitalized patients [9, 10] and can persist in the 
environment [11, 12]. Furthermore, some hospital infection 
control measures such as active screening programs of high-
risk patients to detect and isolate VREfm carriers are not uni-
versally practiced.
The investigation of suspected VREfm outbreaks is triggered 
when 2 or more VREfm-positive individuals are identified in 
the same time and place. This epidemiological approach may be 
complemented by bacterial typing, but available methods lack 
sufficient resolution to distinguish between isolates belonging 
to the same genetic lineage [13]. Whole-genome sequencing 
(WGS) provides greater discrimination between isolates for a 
range of nosocomial pathogens, but the study of E. faecium has 
lagged behind. The first completed E. faecium genome was only 
published in 2012 [14], and subsequent genome-based studies 
have involved relatively small numbers of isolates [13, 15–17]. 
A single study to date has addressed the clinical application of 
E. faecium WGS to patient cohorts, which used a core genome 
multilocus sequence typing scheme and confirmed the utility of 
WGS for the study of E. faecium outbreaks [18]. Here, we report 
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the findings of a large study that establishes a role for genome 
sequencing in the investigation of E. faecium transmission.
METHODS
Microbiology and Sequence Data
A retrospective study was conducted at the Cambridge 
University Hospitals NHS Foundation Trust (CUH), a tertiary 
referral center in the United Kingdom with 1170 beds and 
350 000 occupied-bed-days per year. The average rate of hospi-
tal-associated E. faecium bacteremia at CUH was approximately 
12.5 vancomycin-resistant and 7 vancomycin-susceptible bac-
teremias per 100 000 bed-days between January 2006 and 
December 2012. All patients with E. faecium bloodstream infec-
tion between November 2006 and December 2012 were iden-
tified using the diagnostic microbiology laboratory database 
(n = 342) and cross-referenced with the bacterial freezer archive 
to identify cases with at least 1 stored E. faecium isolate (n = 293). 
Their first stored isolate (200 VREfm, 93 vancomycin-suscepti-
ble E. faecium [VSEfm]) was sequenced, together with the first 
stored isolate from 15 patients with E. faecium bacteremia at 2 
neighboring hospitals (Papworth and Hinchingbrooke) in 2012 
(isolates were not available prior to 2012). All 57 CUH isolates 
from 2012 and an additional 21 CUH isolates from the study 
have been reported previously [19, 20].
Patient location and clinical data at onset of bacteremia were 
collected from paper and electronic medical records for all CUH 
study patients. Additional ward movement data for 1 year prior 
to the bacteremia were collected for all patients included in the 
epidemiological investigation of clustered isolates. Bacteremia 
was categorized as community-acquired, healthcare-associated, 
or hospital-acquired based on the criteria defined by Friedman 
et al [21]. Epidemiological data were not available for patients 
from Papworth and Hinchingbrooke hospitals. The study was 
approved by the National Research Ethics Service (reference 
number 12:/EE/0439) and the CUH Research and Development 
Department.
DNA was extracted using the QIAxtractor instrument 
(QIAgen, Hilden, Germany). Phenotypic susceptibility to 
vancomycin was determined using the British Society for 
Antimicrobial Chemotherapy disk diffusion method [22] or 
the Vitek2 instrument (bioMérieux, Marcy l’Etoile, France) 
with the AST-P607 card. DNA library preparation was con-
ducted according to the Illumina protocol [23], and sequenc-
ing was performed on an Illumina HiSeq2000 with 100-cycle 
paired-end runs. Additional WGS data were sourced from the 
European Nucleotide Archive (ENA) for a further 529 isolates: 
73 from a global collection and 456 from the British Society 
for Antimicrobial Chemotherapy Bacteremia Resistance 
Surveillance Project (www.bsacsurv.org). Details of all 837 
genomes used in this study are provided in Supplementary 
Table 1.
Analysis of Sequence Data
Genome assemblies for the 293 CUH isolates and 73 global iso-
lates were combined and were annotated using Prokka, and a 
pangenome was estimated using Roary [24]. A maximum-like-
lihood tree based on 69 639 single-nucleotide polymorphisms 
(SNPs) in the 1057 conserved genes (present in 100% of isolates) 
was created and lineages were assigned to clade A  and clade 
B based on previous descriptions [16]. Subsequent analyses 
focused on 284 CUH isolates that resided in a clonal expansion 
of clade A. Sequence reads were mapped to E. faecium Aus0004 
(ENA accession number CP003351) using SMALT (http://www.
sanger.ac.uk/resources/software/smalt/). A  “core” genome was 
created for each isolate (1 921 355 to 2 801 515 base pairs [bp], 
representing 65%–95% of the genome) by removing genes anno-
tated as plasmid-, phage-, IS-, or transposon-related, putative 
prophages identified using PHAST (phast.wishartlab.com) [25], 
and recombination identified using Gubbins [26]. Maximum-
likelihood trees were created based on SNPs in the core genome 
using RAxML [27], a midpoint root, and 1000 bootstraps 
(Supplementary Figures 1 and 2). iTOL [28, 29] and FigTree 
were used to visualize the trees. Pairwise differences between 
isolates were calculated based on SNPs in the core genome.
The mutation rate was estimated for a subset of isolates (CUH 
cluster 1). Sequence reads were mapped to an assembly of the old-
est isolate in the cluster using SMALT, and mobile genetic elements 
and recombination events were identified and removed, leaving 
a core genome size of 3 100 085 to 3 212 187 bp. The presence of 
a time signal was evaluated using Path-o-gen and the mutation 
rate estimated using Bayesian Evolutionary Analysis Sampling 
Trees (BEAST) [30]. The best molecular clock and tree model was 
selected based on Bayes factors, calculated using a combination of 
path sampling and stepping stone sampling [31, 32].
The vanA and vanB genes were detected using in silico pol-
ymerase chain reaction (PCR) and published primers [33, 34]. 
SNPs and gene content of vanA transposons were identified 
by mapping to the reference transposon M97297 from E. fae-
cium strain BM4147. DNA from 6 isolates (5 VREfm, 1 VSEfm; 
Supplementary Table 1) was extracted using the phenol/chlo-
roform method [35] and sequenced using the PacBio RS II 
instrument. Sequence reads were assembled using HGAP ver-
sion 3 [36] of the SMRT analysis software version 2.3.0 (https://
github.com/PacificBiosciences/SMRT-Analysis), circularized 
using Circlator version 1.1.3 [37] and polished using the PacBio 
RS_Resequencing protocol and Quiver version 1 (http://github.
com/PacificBiosciences/SMRT-Analysis). Plasmids carrying 
vanA were identified using in silico PCR, as above. Fully assem-
bled plasmids were compared using WebACT (http://www.
webact.org) and BLASTn (https://blast.ncbi.nlm.nih.gov). The 
VSEfm isolate was interrogated for the presence of a vanA-neg-
ative plasmid, which was compared with the vanA-positive 
plasmid in a closely related VREfm isolate using WebACT and 
BLASTn.
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RESULTS
Study Cohort and Bacterial Isolates
A total of 342 patients were identified as having E. faecium bac-
teremia at CUH between November 2006 and December 2012. 
Of these, at least 1 isolate was available for 293 (86%) cases and 
were the basis of further analysis. The majority of cases were 
hospital-acquired (n = 249) or healthcare-associated (n = 42), 
with only 2 cases fulfilling the criterion for community-ac-
quired infection [21]. The most common specialties at the time 
of bacteremia were hematology (28%), transplantation (12%), 
general surgery (11%), hepatology (10%), and pediatric hema-
tology-oncology (10%).
CUH E. faecium Genomes in a Global Context
We defined the phylogeny of the 293 CUH E. faecium isolates 
within the broader genetic context of 73 global E. faecium isolates 
used previously to delineate hospital- and community-associ-
ated lineages [16]. A maximum-likelihood tree was constructed 
based on SNPs in the conserved genes (Supplementary 
Figure 3). This showed that 291 of 293 (99%) CUH genomes 
resided within a lineage categorized previously as hospital-as-
sociated (clade A) [16], and were interspersed with global iso-
lates. The remaining 2 study genomes (both VSEfm) clustered 
with those categorized previously as community-associated or 
commensal (clade B) [16]. Contrary to expectations, both clade 
B isolates were healthcare-associated, and the 2 community-ac-
quired infections were caused by clade A isolates.
We noted that 284 of the 293 CUH genomes formed a 
highly related clonal expansion within clade A (Supplementary 
Figure  3). We reconstructed a maximum-likelihood tree for 
these 284 study isolates based on 4212 SNPs after mapping to 
a reference and removing recombination (Figure 1A). Overall 
genetic diversity was high, but the most striking feature was the 
presence of numerous clusters of highly related isolates. This is 
indicative of multiple introductions of E.  faecium into CUH, 
followed by clonal expansion associated with persistence and 
transmission over time. Genetic relatedness was also reflected 
in a systematic pairwise SNP comparison, which showed that 
56% of genomes were within 0–6 SNPs of at least 1 other iso-
late (falling within the estimate for within-host diversity [19]) 
(Figure  1B). This included 11% that were identical to at least 
1 other isolate at the core genome level. Bacteremia represents 
the “tip of the iceberg” in terms of E. faecium burden, and we 
propose that these were linked to larger covert E. faecium popu-
lations associated with carriage and/or environmental contami-
nation within this hospital setting.
Evidence for E. faecium Transmission at CUH
We undertook a detailed transmission analysis taking into 
account patient movement and mutation rate. The E. faecium 
mutation rates reported previously are inconsistent (approxi-
mately 5 SNPs/genome/year [15] and approximately 147 SNPs/
genome/year [16]). To reconcile this, we estimated the mutation 
rate for isolates in CUH cluster 1 (Figure 1A) (the second-larg-
est cluster, containing 29 isolates drawn from each year between 
2007 and 2012). A BEAST analysis gave an estimated mutation 
rate of approximately 7 SNPs/genome/year (2.3 × 10-6 SNPs/
site/year) (Supplementary Figure 4).
We evaluated the relatedness of isolates in 6 exemplar genetic 
clusters (termed CUH clusters 1–6), which together contained 
93 isolates (Figure 1A). The pairwise SNP distance within each 
cluster after removal of regions of recombination is provided in 
Supplementary Table 2. The majority of isolates in each cluster 
were closely related or fell within the estimated mutation rate 
of 7 SNPs/genome/year, indicating that these patients were epi-
demiologically linked. The exceptions were 4 of 40 isolates in 
cluster 3 that were up to 23 SNPs from the closest genetic match. 
To determine the importance of accounting for recombination 
in outbreak analyses, we repeated the pairwise comparison of 
the core genome before recombination blocks were removed 
(Supplementary Table  2). This demonstrated a predictable 
increase in median pairwise SNP difference for all 6 clusters by 
a factor of between 1.9 and 3.6. Taking into account the esti-
mated mutation rate, an additional 19 isolates were >7 SNPs/
genome/year apart, demonstrating the importance of account-
ing for recombination events in these analyses.
Two isolates in cluster 3 had been suspected previously to 
be part of a ward-based outbreak in 2010 [38], but sequenc-
ing revealed that these belonged to a much larger cluster con-
taining isolates from multiple specialties and dating back to 
2008 (Figure 1A). This pattern was mirrored in 4 of the 5 other 
clusters, which contained isolates from numerous specialties 
(Figure 1A), and 3 clusters that contained isolates drawn from 
3 or more years (Figure 1C). These data confirm that transmis-
sion had extended far beyond just a single ward and time-point.
To provide further evidence for the utility of genome 
sequencing in transmission investigations, we linked genomes 
with patient ward-movement data for the 6 CUH clusters to 
visualize the different transmission dynamics. Clusters 2, 4, 
and 6 are shown in Figure 2 as representatives of the different 
transmission routes identified. Cluster 6 involved 4 patients on 
the same ward (1–7 SNPs different [median,  5]) (Figure  2A). 
Three patients had overlapping admission dates and the fourth 
had a later, nonoverlapping admission date. This is suggestive 
of a ward-based outbreak with indirect spread (either from the 
environment or from unsampled carriers) to the fourth case. 
Cluster 4 involved 7 patients (1–14 SNPs different [median, 7]) 
(Figure 2B) and was more complex, involving 2 wards belong-
ing to different specialties located on different floors of the hos-
pital. This provided evidence for direct/indirect transmission 
between patients sharing the same ward at the same time (eg, 
patients 14 and 16), and indirect transmission between patients 
sharing the same ward at different times (eg, patients 23 and 
26). Two patients only developed bloodstream infection after 
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transfer to different wards, which obscured links to the likely 
original source. Figure  2C shows CUH cluster 2, involving 
7 patients (1–7 SNPs different [median,  4]). This cluster was 
unsupported by any clear epidemiological evidence, suggesting 
widespread dissemination in the hospital, which could be medi-
ated by carriers or represent a communal source.
Interhospital E. faecium Transmission
To evaluate the relatedness of E.  faecium between hospitals at 
regional and national levels, we combined the genomes from 
CUH patients with those of 456 E.  faecium bacteremia iso-
lates from 39 hospitals across the United Kingdom and Ireland 
between 2001 and 2011, and 15 isolates associated with bacte-
remia (in 15 patients) at 2 geographically related hospitals, all 
of which resided in the clonal expansion of clade A. A maxi-
mum-likelihood tree demonstrated that CUH clusters 1, 2, and 
3 contained isolates from patients at other hospitals, including 
one from nearby Hinchingbrooke hospital and 6 from other 
hospitals within our geographic region (East Anglia), indicating 
regional interhospital transmission (Figure 3). We also identi-
fied an isolate that resided in CUH cluster 3 that was originally 
cultured in the northeast of England, suggesting E.  faecium 
transmission between CUH and geographically distant hos-
pitals. CUH isolates were distributed throughout the national 
collection, supporting the suggestion of multiple introductions 
into CUH.
VSEfm and VREfm Are Interspersed in Transmission Clusters
We compared the genomes of the 200 CUH VREfm (197 
vanA positive, 2 vanB positive, and 1 isolate containing both 
genes) and 93 CUH VSEfm (Figure  1A). Focusing again on 
clusters 1–6, we found that 3 clusters (1, 3, and 5)  contained 
both VSEfm and VREfm, whereas the remainder contained 
VREfm alone. To explore the extent to which the gain and 
loss of resistance was a dynamic process, we compared the 
genetic relatedness of transposons that carry the gene encoding 
Figure 1. Phylogenetic analyses of Enterococcus faecium associated with bloodstream infection in 284 patients at Cambridge University Hospitals NHS Foundation Trust 
demonstrate numerous independent clades associated with nosocomial transmission. A, Maximum likelihood tree of 284 isolates. Colored dots indicate presence of vanA 
(red), vanB (yellow), vanA and vanB (orange), or absence of van genes (blue). Clusters 1–6 are used as examples for detailed analyses, and show the medical specialty for 
each case at the time of bacteremia (blue outer ring). Asterisks indicate isolates in cluster 3 that were not classified as closely related to other isolates in the cluster based 
on single-nucleotide polymorphism (SNP) differences. Scale bar indicates 84 SNPs. B, Pairwise SNP comparison for the 284 isolates shows the closest genetic match for each 
isolate. Red, vancomycin-resistant E. faecium (VREfm); blue, vancomycin-susceptible E. faecium (VSEfm). C, Number of isolates per year for clusters 1–6 (n = 93), starting from 
the earliest isolation date (day zero) in each cluster.
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vancomycin resistance (vanA). Four of the 6 clusters each con-
tained >1 transposon type as defined by deletions and/or SNPs 
(Supplementary Figure  5), suggesting de novo acquisition of 
vancomycin resistance by hospital-circulating VSEfm lineages. 
The phylogeny additionally indicated that within each of the 
CUH clusters 1, 3, and 5, isolates had either gained or lost the 
transposon on >1 occasion.
To further investigate the loss/gain of vanA, we performed 
long-read sequencing of 6 isolates: 2 from cluster 6 with dif-
ferent transposons based on analysis of short-read data; and 4 
from cluster 1, of which 3 had the same transposon based on 
analysis of short-read data (the earliest [2007], 1 from 2009, 
and latest [2012] isolate in this cluster), and a VSEfm that was 
0 SNPs apart from the 2009 VREfm at the core genome level. 
Comparison of vanA-positive plasmids from cluster 6 con-
firmed that these were distinct (99% identity but only 51% of 
the sequence covered [present], Supplementary Figure  6A), 
indicating the acquisition of >1 vanA plasmid by this lineage. In 
contrast, the 3 vanA plasmids from cluster 1 were closely related 
(99% identity and 100% covered; Supplementary Figure  6B), 
indicating either a single acquisition event followed by loss by a 
proportion of the population over time, or multiple acquisition 
events. Of interest, the plasmid from the earliest isolate from 
cluster 1 had a 21-kb region that was inverted in comparison 
to the other 2 plasmids, which included the vanA transposon 
and was located adjacent to a transposase. The VSEfm genome 
contained a plasmid that was highly related to the vanA plasmid 
carried by the closest genetic VREfm relative (99% identity, 81% 
covered), with loss of vanA being part of an approximate 25-kb 
deletion. These observations concur with the analysis based on 
short-read data.
DISCUSSION
Our study represents an unbiased investigation of E.  faecium 
from patients with bloodstream infections over a 7-year period 
and provides a large-scale overview within a single hospital, and 
between this and the broader healthcare network. We found 
that >50% of isolates were highly related to at least 1 other iso-
late. The use of patient admission and ward movement data 
Figure 2. Complex patterns of Enterococcus faecium transmission. The combination of genetic E. faecium clusters and patient location and movement data over time 
revealed several patterns of spread. Admission timeline for each patient is shown, with patient ID on the y-axis. Blocks indicate duration of hospital stay. The color of each 
block is unique to a specific ward or unit. Black dots denote a bloodstream infection, the isolate from which was sequenced. A, Patients in cluster 6 involved in a single 
ward transmission. The first 3 cases on ward A (purple) had overlapping admission dates indicative of an outbreak due to direct or indirect spread. The fourth case occurred 
many months later. B, Isolates in cluster 4 involved in transmission within and between 2 different wards (blue and orange). C, Isolates in cluster 2 from numerous wards.
Figure 3. Genetic relatedness between Enterococcus faecium from Cambridge University Hospitals NHS Foundation Trust (CUH) patients and a collection from the UK and 
Ireland. Maximum likelihood tree based on single-nucleotide polymorphisms (SNPs) in the core genome of isolates from the clonal expansion of clade A. Outer ring indicates 
isolates from CUH (red), 15 isolates from patients with bacteremia in 2 hospitals close to CUH (yellow), and 456 isolates from patients with bacteremia in the UK and Ireland 
(dark blue). Clusters 1–6 are also indicated (clockwise from 1 o'clock: cluster 5, light blue; cluster 3, dark green; cluster 2, red; cluster 4, purple; cluster 6, light green; cluster 
1, dark blue). Scale bar indicates approximately 100 SNPs.
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allowed us to identify transmission events in individual wards, 
but combining this with genome data also revealed more com-
plex links between cases that would not have been detected 
by epidemiological investigation alone. This included patients 
who appeared to acquire their infecting isolate in one ward but 
developed bloodstream infection after transfer to another ward, 
and more complex routes created by patient movement through 
multiple wards. This implies that targeted infection control 
interventions triggered by outbreak investigations would only 
be partially effective.
Our findings are supported by previous studies that 
reported E. faecium with the same pulsed-field gel electropho-
resis type on >1 ward [39, 40], suggesting that the complex 
transmission routes identified in this study exist elsewhere. 
Additionally, interhospital transmission has been suggested 
in both Denmark and Australia based on WGS data [13, 15], 
indicating that this is a globally relevant problem. To date, 
within-hospital WGS studies have been focused in Australia 
[15, 17], where the vanB type of vancomycin resistance pre-
dominates. These studies identified polyclonal hospital popu-
lations, supporting our finding of multiple introductions, and 
hinted at the presence of within-hospital VRE clones, although 
small isolate numbers (7 and 4 isolates) limited the power to 
draw robust conclusions from this. Our study extends current 
knowledge by using more than double the number of isolates 
used in previous studies to provide the largest and most com-
prehensive investigation of inter- and intrahospital dynamics 
of VRE to date, and the first high-resolution insight into the 
vanA setting.
A limitation of our work was its restriction to bacteremia 
isolates, which constitutes a fraction of the overall VRE bur-
den. Carriers, healthcare workers, and environmental sur-
faces provide a large “silent” reservoir for transmission [12, 
41, 42]. As a result, the prevalence of intra- and interhospital 
Figure 3. Genetic relatedness between Enterococcus faecium from Cambridge University Hospitals NHS Foundation Trust (CUH) patients and a collection from the UK and 
Ireland. Maximum likelihood tree based on single-nucleotide polymorphisms (SNPs) in the core genome of isolates from the clonal expansion of clade A. Outer ring indicates 
isolates from CUH (red), 15 isolates from patients with bacteremia in 2 hospitals close to CUH (yellow), and 456 isolates from patients with bacteremia in the UK and Ireland 
(dark blue). Clusters 1–6 are also indicated (clockwise from 1 o'clock: cluster 5, light blue; cluster 3, dark green; cluster 2, red; cluster 4, purple; cluster 6, light green; cluster 
1, dark blue). Scale bar indicates approximately 100 SNPs.
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transmissions are likely to be much higher than reported here. 
Nonetheless, our findings have important implications for 
hospital infection control. First, the scope of infection control 
investigations for suspected VREfm outbreaks requires the 
inclusion of multiple wards and specialties, the potential com-
plexity of which could be simplified by bacterial sequencing. 
Second, our findings indicate a need to review guidelines to 
include VSEfm in VREfm control measures since vancomycin 
resistance appears to be repeatedly introduced into the vanco-
mycin-susceptible population of hospital-adapted lineages, as 
documented previously for vanB-positive VREfm in Australia 
[15]. Third, our data revealed multiple introductions of E. fae-
cium into CUH with subsequent dissemination, emphasiz-
ing the importance of active screening to detect carriers in 
conjunction with isolation to prevent onward transmission. 
Active screening reduces the rates of VRE infection [43], and 
countries that implement this strategy (eg, Finland and the 
Netherlands) have considerably lower rates of VRE infection 
than the United Kingdom [44].
We conclude that the introduction of routine WGS of E. fae-
cium into hospitals would represent a powerful adjunct to exist-
ing infection control methods.
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